A detailed history of Kelly Financial Services LLC transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Kelly Financial Services LLC holds 4,000 shares of AVXL stock, worth $21,840. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,000
Previous 4,000 -0.0%
Holding current value
$21,840
Previous $20,000 20.0%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Jul 17, 2024

SELL
$16.82 - $25.75 $1.47 Million - $2.25 Million
-87,440 Reduced 95.63%
4,000 $71.8 Million
Q2 2021

Jul 17, 2024

BUY
$10.16 - $28.86 $898,550 - $2.55 Million
88,440 Added 2948.0%
91,440 $4 Million
Q1 2021

Jul 17, 2024

BUY
$5.17 - $16.13 $14,476 - $45,164
2,800 Added 1400.0%
3,000 $44.9 Million
Q4 2020

Jul 17, 2024

BUY
$4.01 - $7.58 $802 - $1,516
200 New
200 $1.08 Million

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $426M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.